German Biobank Node (GBN)

What German Biobank Node (GBN) does

The German Biobank Node (GBN) is a non-profit research coordination network that connects biobanks across Germany to provide researchers in academia and industry with on-demand access to quality-assured biological samples (bioproben) and associated clinical and analytical data. Headquartered at Charité Berlin and operating as a core component within the Netzwerk Universitätsmedizin (NUM), GBN functions as the German national node of BBMRI-ERIC, the European research infrastructure for biobanking. Its core products include the nationwide German Biobank Network platform, sample discovery services, quality management with BBMRI-ERIC certification support, IT infrastructure integration, training and education programs, and ELSI (Ethical, Legal, and Social Implications) advisory services.

GBN's business model is institutional rather than commercial: the organization is funded through governmental and academic research grants channeled via NUM and Charité Berlin, with no publicly disclosed pricing or commercial revenue streams. GTM is community-led, relying on partnerships with German biobanks, participation in events such as Europe Biobank Week, and digital channels including LinkedIn, YouTube, Vimeo, Bluesky, and a newsletter. The organization serves three primary segments: professional biobanks (supply-side), researchers in academia and industry (demand-side), and patients and relatives (public engagement/education).

The technical foundation is a federated biobank network architecture connecting multiple German biobanks through standardized quality management and IT integration. In June 2026, GBN initiated construction of the 'Biobank-Plattform für Deutschland', a new unified national platform designed to centralize researcher access to biobank resources across the country—a significant infrastructure investment that signals the next phase of the organization's development.

Name

German Biobank Node (GBN)

Legal name

German Biobank Node (GBN)

Website

https://bbmri.de

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

German Biobank Node (GBN) is a non-profit coordination network, based at Charité Berlin within the Netzwerk Universitätsmedizin, that connects German biobanks to give academic and industry researchers standardized access to quality-assured biological samples and clinical data.

Ownership category

akta.pro rank

Product category

Biobanking Research Infrastructure

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Biobank & Biospecimen Management LIMS (HLACAMAG)

Keywords

• Biobanking infrastructure
• Biological sample access
• Biobank quality management
• Clinical research data
• Biomedical research network

Headquarters

HQ city

Berlin

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Others

Revenue model

1. Network Coordination Funding: GBN operates as part of the Netzwerk Universitätsmedizin (NUM) and receives institutional funding for coordinating the German biobank network. Revenue appears to come from government/academic research funding rather than commercial operations.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

German Biobank Node (GBN) operates a nationwide federated network that connects professional biobanks across Germany, enabling researchers in academia and industry to find and access quality-assured biological samples (bioproben) and associated clinical/analytical data on demand. It also provides participating biobanks with quality management frameworks, IT infrastructure, training, ELSI (Ethical, Legal, and Social Implications) advisory, and BBMRI-ERIC certification support, and is building a unified national Biobank Platform for Germany (kick-off June 2026).

Product overview

German Biobank Node (GBN) operates as a centralized network platform connecting biobanks across Germany. The core offering is the nationwide Biobank Network that provides researchers with on-demand access to quality-assured biological samples and associated clinical/analytical data. Supporting services include Quality Management (with BBMRI-ERIC Quality Label certification support), IT infrastructure, Training and Education programs, ELSI advisory services, Sample Discovery services for researchers, and Research coordination support. The organization is currently building a dedicated 'Biobank Platform for Germany' as announced in June 2026.

Differentiator

Problem solved

Functional benefit

Products and services

• German Biobank Network (GBN)

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Three partnerships are on record, tiered core.

• Biobank-Plattform für DeutschlandcoreStrategic or Co-development Partner · 22 June 2026The 'Biobank Platform for Germany' is a new initiative starting in June 2026 to build a unified national biobank platform. This platform will enable researchers to find suitable bioproben and associated clinical/analytical data through a centralized access point, representing a major infrastructure development for German biomedical research.
• BBMRI-ERICcoreStrategic or Co-development PartnerBBMRI-ERIC is the European research infrastructure for biobanking. GBN is the German national node of this European network, participating in quality certification programs (Quality Labels), contributing to European standardization efforts, and representing German biobanking interests in the broader European research ecosystem.
• Netzwerk Universitätsmedizin (NUM)coreStrategic or Co-development PartnerNUM (Network University Medicine) is the parent organization that houses GBN. The integration brings biobanks and researchers closer together, enabling better coordination between sample providers and the medical research community. GBN operates as a core component within the NUM infrastructure.

Scale indicators1 record

Recent moves4 records

Expansion highlights4 records

Market position

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@NetzwerkUniversit%C3%A4tsmedizin
• LinkedInlinkedin.com/company/german-biobank-node

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about German Biobank Node (GBN)